Correlation between RAB27B and p53 Expression and Overall Survival in Pancreatic Cancer

Pancreas

Volumn 45, Issue 2, 2016, Pages 204-210

  Zhao, Hui ^a   Wang, Qingqing ^a   Wang, Xudong ^a   Zhu, Huijun ^a   Zhang, Shu ^a   Wang, Wei ^a   Wang, Zhiwei ^a   Huang, Jianfei ^a  

^a NANTONG UNIVERSITY   (China)

Author keywords

immunohistochemistry; p53; pancreatic ductal adenocarcinoma; prognosis; RAB27B

Indexed keywords

PROTEIN P53; RAB PROTEIN; RAB27B PROTEIN; UNCLASSIFIED DRUG; RAB27B PROTEIN, HUMAN; TUMOR MARKER;

ADULT; ARTICLE; CANCER PATIENT; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DISTANT METASTASIS; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PANCREAS CANCER; PANCREATIC TISSUE; PERINEURAL INVASION; PRIORITY JOURNAL; PROTEIN EXPRESSION; TISSUE MICROARRAY; TUMOR INVASION; BIOSYNTHESIS; KAPLAN MEIER METHOD; METABOLISM; METASTASIS; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; PANCREAS CARCINOMA; PANCREAS TUMOR; PATHOLOGY; SURVIVAL ANALYSIS;

BIOMARKERS, TUMOR; CARCINOMA, PANCREATIC DUCTAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NEOPLASM STAGING; PANCREATIC NEOPLASMS; RAB GTP-BINDING PROTEINS; SURVIVAL ANALYSIS; TISSUE ARRAY ANALYSIS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84955725907     PISSN: 08853177     EISSN: 15364828     Source Type: Journal    
DOI: 10.1097/MPA.0000000000000453     Document Type: Article

References (34)

1. Jemal A, Bray F, Center MM, Global cancer statistics. CA Cancer J Clin. 2011; 61: 69-90.
2. Luo J, Xiao L, Wu C, The incidence and survival rate of population-based pancreatic cancer patients: Shanghai Cancer Registry 2004-2009. PLoS One. 2013; 8: e76052.
3. Bilimoria KY, Bentrem DJ, Ko CY, Validation of the 6th edition AJCC Pancreatic Cancer Staging System: report from the National Cancer Database. Cancer. 2007; 110: 738-744.
4. He XY, Yuan YZ,. Advances in pancreatic cancer research: moving towards early detection. World J Gastroenterol. 2014; 20: 11241-11248.
5. Bilici A,. Prognostic factors related with survival in patients with pancreatic adenocarcinoma. World J Gastroenterol. 2014; 20: 10802-10812.
6. Peinado H, Aleckovic M, Lavotshkin S, Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET. Nat Med. 2012; 18: 883-891.
7. Hoshino D, Kirkbride KC, Costello K, Exosome secretion is enhanced by invadopodia and drives invasive behavior. Cell Rep. 2013; 5: 1159-1168.
8. Bhatia A, Kumar Y,. Cellular and molecular mechanisms in cancer immune escape: a comprehensive review. Expert Rev Clin Immunol. 2014; 10: 41-62.
9. Bobrie A, Krumeich S, Reyal F, Rab27a supports exosome-dependent and-independent mechanisms that modify the tumor microenvironment and can promote tumor progression. Cancer Res. 2012; 72: 4920-4930.
10. Chen D, Guo J, Miki T, Molecular cloning and characterization of rab27a and rab27b, novel human rab proteins shared by melanocytes and platelets. Biochem Mol Med. 1997; 60: 27-37.
11. Chen Y, Samaraweera P, Sun TT, Rab27b association with melanosomes: dominant negative mutants disrupt melanosomal movement. J Invest Dermatol. 2002; 118: 933-940.
12. Hendrix A, Lambein K, Westbroek W, An immunohistochemical analysis of Rab27B distribution in fetal and adult tissue. Int J Dev Biol. 2012; 56: 363-368.
13. Hendrix A, Maynard D, Pauwels P, Effect of the secretory small GTPase Rab27B on breast cancer growth, invasion, and metastasis. J Natl Cancer Inst. 2010; 102: 866-880.
14. Zhang JX, Huang XX, Cai MB, Overexpression of the secretory small GTPase Rab27B in human breast cancer correlates closely with lymph node metastasis and predicts poor prognosis. J Transl Med. 2012; 10: 242.
15. Ho JR, Chapeaublanc E, Kirkwood L, Deregulation of Rab and Rab effector genes in bladder cancer. PLoS One. 2012; 7: e39469.
16. Dong WW, Mou Q, Chen J, Differential expression of Rab27A/B correlates with clinical outcome in hepatocellular carcinoma. World J Gastroenterol. 2012; 18: 1806-1813.
17. Hollstein M, Sidransky D, Vogelstein B, p53 mutations in human cancers. Science. 1991; 253: 49-53.
18. Vogelstein B, Kinzler KW,. p53 function and dysfunction. Cell. 1992; 70: 523-526.
19. Dutta S, Warshall C, Bandyopadhyay C, Interactions between exosomes from breast cancer cells and primary mammary epithelial cells leads to generation of reactive oxygen species which induce DNA damage response, stabilization of p53 and autophagy in epithelial cells. PLoS One. 2014; 9: e97580.
20. Feng Z,. p53 regulation of the IGF-1/AKT/mTOR pathways and the endosomal compartment. Cold Spring Harb Perspect Biol. 2010; 2: a001057.
21. Yu X, Riley T, Levine AJ,. The regulation of the endosomal compartment by p53 the tumor suppressor gene. FEBS J. 2009; 276: 2201-2212.
22. Yu X, Harris SL, Levine AJ,. The regulation of exosome secretion: a novel function of the p53 protein. Cancer Res. 2006; 66: 4795-4801.
23. Casey G, Yamanaka Y, Friess H, p53 mutations are common in pancreatic cancer and are absent in chronic pancreatitis. Cancer Lett. 1993; 69: 151-160.
24. Cowley MJ, Chang DK, Pajic M, Understanding pancreatic cancer genomes. J Hepatobiliary Pancreat Sci. 2013; 20: 549-556.
25. Detre S, Saclani Jotti G, Dowsett M,. A "quickscore" method for immunohistochemical semiquantitation: validation for oestrogen receptor in breast carcinomas. J Clin Pathol. 1995; 48: 876-878.
26. Ni S, Xu L, Huang J, Increased ZO-1 expression predicts valuable prognosis in non-small cell lung cancer. Int J Clin Exp Pathol. 2013; 6: 2887-2895.
27. Zhai X, Zhu H, Wang W, Abnormal expression of EMT-related proteins, S100A4, vimentin and E-cadherin, is correlated with clinicopathological features and prognosis in HCC. Med Oncol. 2014; 31: 970.
28. Hendrix A, Braems G, Bracke M, The secretory small GTPase Rab27B as a marker for breast cancer progression. Oncotarget. 2010; 1: 304-308.
29. + ATPase expression and activity is required for Rab27B-dependent invasive growth and metastasis of breast cancer. Int J Cancer. 2013; 133: 843-854.
30. Nagata K, Itoh H, Katada T, Purification, identification, and characterization of two GTP-binding proteins with molecular weights of 25,000 and 21,000 in human platelet cytosol. One is the rap1/smg21/Krev-1 protein and the other is a novel GTP-binding protein. J Biol Chem. 1989; 264: 17000-17005.
31. Wright PK, May FE, Darby S, Estrogen regulates vesicle trafficking gene expression in EFF-3, EFM-19 and MCF-7 breast cancer cells. Int J Clin Exp Pathol. 2009; 2: 463-475.
32. Lespagnol A, Duflaut D, Beekman C, Exosome secretion, including the DNA damage-induced p53-dependent secretory pathway, is severely compromised in TSAP6/Steap3-null mice. Cell Death Differ. 2008; 15: 1723-1733.
33. Lehmann BD, Paine MS, Brooks AM, Senescence-associated exosome release from human prostate cancer cells. Cancer Res. 2008; 68: 7864-7871.
34. Amzallag N, Passer BJ, Allanic D, TSAP6 facilitates the secretion of translationally controlled tumor protein/histamine-releasing factor via a nonclassical pathway. J Biol Chem. 2004; 279: 46104-46112.